Waters Corporation EBITDA Margin

EBITDA Margin of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBITDA Margin growth rates and interactive chart.


Highlights and Quick Summary

  • EBITDA Margin for the quarter ending December 30, 2020 was 37.88% (a 18.82% increase compared to previous quarter)
  • Year-over-year quarterly EBITDA Margin increased by 80.73%
  • Annual EBITDA Margin for 2020 was 32.59% (a -3.61% decrease from previous year)
  • Annual EBITDA Margin for 2019 was 33.81% (a -3.54% decrease from previous year)
  • Annual EBITDA Margin for 2018 was 35.05% (a 5.35% increase from previous year)
  • Twelve month EBITDA Margin ending December 30, 2020 was 32.59% (a 1.88% increase compared to previous quarter)
  • Twelve month trailing EBITDA Margin increased by 0.4% year-over-year
Trailing EBITDA Margin for the last four month:
30 Dec '20 29 Sep '20 29 Jun '20 30 Mar '20
32.59% 31.99% 32.69% 32.46%
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBITDA Margin of Waters Corporation

Most recent EBITDA Marginof WAT including historical data for past 10 years.

Interactive Chart of EBITDA Margin of Waters Corporation

Waters Corporation EBITDA Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 37.88% 31.88% 35.8% 20.96% 32.59%
2019 36.49% 34.63% 34.47% 28.4% 33.81%
2018 37.78% 34.37% 34.62% 32.6% 35.05%
2017 37.59% 32.69% 32.84% 28.45% 33.27%
2016 37.07% 33.41% 32.85% 28.64% 33.29%
2015 34.84% 31.48% 30.91% 30.96% 32.19%
2014 33.52% 34.09% 28.89% 25.34% 30.77%
2013 34.95% 30.53% 29.29% 29.67% 31.35%
2012 33.93% 31.64% 30.16% 29.68% 31.48%
2011 34.75% 31.65% 30.8% 30.88% 32.14%
2010 34.17% 29.68% 30.91% 31.19%

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.